Modeling Cervical Cancer Prevention in Developed Countries
- 19 August 2008
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 26, K76-K86
- https://doi.org/10.1016/j.vaccine.2008.06.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mathematical Models of Cervical Cancer Prevention in the Asia Pacific RegionVaccine, 2008
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 VaccinationJNCI Journal of the National Cancer Institute, 2008
- Cost-Effectiveness Analyses of Vaccination ProgrammesPharmacoEconomics, 2008
- Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationPopulation Health Metrics, 2007
- The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource settingBritish Journal of Cancer, 2007
- Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in FinlandBritish Journal of Cancer, 2007
- Model for Assessing Human Papillomavirus Vaccination StrategiesEmerging Infectious Diseases, 2007
- Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UKBritish Journal of Cancer, 2006
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLoS Medicine, 2006
- Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and ItalyJNCI Journal of the National Cancer Institute, 2005